US CDC advisers vote in favor of Pfizer/BioNTech vaccine after full approval

An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech Se COVID-19 vaccine for people age 16 and older, an important step after it gained full U.S. approval last week.

The Food and Drug Administration last week granted full approval to the vaccine that was previously available under the agency's emergency use authorization (EUA), which had allowed the shots to be rolled out rapidly to Americans. Health officials hope the formal approval will spur more Americans to get vaccinated. With full FDA approval, some companies and states have begun mandating COVID-19 vaccination.